Society often discourages people from judging others despite being made of a wholly judgmental populace. As it turns out, looking down on others for being despicable is actually a good thing, at least to some extent. According to a new study, judging someone’s morality is actually a great way to gain their cooperation when working on a project as a group. Who knew that being self-righteous is actually useful?
The study led by a researcher at Stanford where participants were actually encouraged to judge the morality of others in the group, Phys.org reports. As it turns out, the participants put such a high value on their reputation that they would put in extra effort in order to make sure that the others would have nothing but high praises for them.
Robb Willer, a Stanford sociologist worked with University of South Carolina researchers to see what people would do if they knew their morals were being openly judged. It was also a way to a shine a light on a concept that is prevalent in society and is surrounded by misconceptions.
"Generally, people think of moral judgments negatively," Willer explained. "But they are a critical means for encouraging good behavior in society."
In the paper that the researchers published, they noted how past studies have often looked at the individual process of judging morality rather than in a social setting. The participants in their particular research developed more trust in one another, which is counter to what most people would think in terms of the effects of being judgmental.
“In a laboratory experiment, groups whose members could make moral judgments achieved greater cooperation than groups with no capacity to sanction, levels comparable to those of groups featuring costly material sanctions,” the study reads. “In addition, members of moral judgment groups subsequently showed more interpersonal trust, trustworthiness, and generosity than all other groups.”


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
The four types of dementia most people don’t know exist
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Why the future of marijuana legalization remains hazy despite high public support
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 



